Literature DB >> 21775132

MicroRNA-21 suppression impedes medulloblastoma cell migration.

Eveline Grunder1, Rocco D'Ambrosio, Giulio Fiaschetti, Lucia Abela, Alexandre Arcaro, Tycho Zuzak, Hiroko Ohgaki, Sheng-Qing Lv, Tarek Shalaby, Michael Grotzer.   

Abstract

Medulloblastoma (MB), the most common malignant brain tumour in children, is characterised by a high risk of leptomeningeal dissemination. But little is known about the molecular mechanisms that promote cancer cell migration in MB. Aberrant expression of miR-21 is recognised to be causatively linked to metastasis in a variety of human neoplasms including brain tumours; however its function in MB is still unknown. In this study we investigated the expression level and the role of miR-21 in MB cell migration. miR-21 was found to be up-regulated, compared to normal cerebellum, in 29/29 MB primary samples and 6/6 MB-derived cell lines. Inverse correlation was observed between miR-21 expression and the metastasis suppressor PDCD4, while miR-21 repression increased the release of PDCD4 protein, suggesting negative regulation of PDCD4 by miR-21 in MB cells. Anti-miR-21 decreased protein expression of the tumour cell invasion mediators MAP4K1 and JNK, which are also known to be negatively regulated by PDCD4, and down-regulated integrin protein that is essential for MB leptomeningeal dissemination. Moreover miR-21 knockdown in MB cells increased the expression of two eminent negative modulators of cancer cell migration, E-Cadherin and TIMP2 proteins that are known to be positively regulated by PDCD4. Finally and importantly, suppression of miR-21 decreased the motility of MB cells and reduced their migration across basement membranes in vitro. Together, these compelling data propose miR-21 pathway as a novel mechanism impacting MB cell dissemination and raises the possibility that curability of selected MB may be improved by pharmaceutical strategies directed towards microRNA-21.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775132     DOI: 10.1016/j.ejca.2011.06.041

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  29 in total

1.  A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells.

Authors:  Hui Xiao; Hemant Kumar Bid; David Jou; Xiaojuan Wu; Wenying Yu; Chenglong Li; Peter J Houghton; Jiayuh Lin
Journal:  J Biol Chem       Date:  2014-10-13       Impact factor: 5.157

2.  Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway.

Authors:  Zimin Liu; Jian Zhang; Guangchen Hong; Jinping Quan; Lin Zhang; Meiqin Yu
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

3.  Suppression of STAT3 NH2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21.

Authors:  Sutapa Ray; Don W Coulter; Shawn D Gray; Jason A Sughroue; Shrabasti Roychoudhury; Erin M McIntyre; Nagendra K Chaturvedi; Kishor K Bhakat; Shantaram S Joshi; Timothy R McGuire; John G Sharp
Journal:  Mol Carcinog       Date:  2018-01-25       Impact factor: 4.784

4.  Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines.

Authors:  Ricardo Bonfim-Silva; Karina Bezerra Salomão; Thais Valéria Costa de Andrade Pimentel; Camila Cristina Branquinho de Oliveira Menezes; Patrícia Vianna Bonini Palma; Aparecida Maria Fontes
Journal:  Cytotechnology       Date:  2019-07-26       Impact factor: 2.058

Review 5.  Medulloblastoma: recurrence and metastasis.

Authors:  Donya Aref; Sidney Croul
Journal:  CNS Oncol       Date:  2013-07

6.  MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development.

Authors:  Lena Constantin; Myrna Constantin; Brandon J Wainwright
Journal:  Genetics       Date:  2016-01-15       Impact factor: 4.562

Review 7.  From small to big: microRNAs as new players in medulloblastomas.

Authors:  Feng Zhi; Suinuan Wang; Rong Wang; Xiwei Xia; Yilin Yang
Journal:  Tumour Biol       Date:  2012-11-25

Review 8.  miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Authors:  Xin Wang; Borja L Holgado; Vijay Ramaswamy; Stephen Mack; Kory Zayne; Marc Remke; Xiaochong Wu; Livia Garzia; Craig Daniels; Anna M Kenney; Michael D Taylor
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

9.  The Emerging Field of Noncoding RNAs and Their Importance in Pediatric Diseases.

Authors:  Rui Zhou; Piyush Joshi; Keisuke Katsushima; Weihong Liang; Wei Liu; Neil A Goldenberg; George Dover; Ranjan J Perera
Journal:  J Pediatr       Date:  2020-06       Impact factor: 4.406

10.  MicroRNAs in Neurotoxicity.

Authors:  Prameet Kaur; Arunmozhiarasi Armugam; Kandiah Jeyaseelan
Journal:  J Toxicol       Date:  2012-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.